The AHA today submitted comments on the Food and Drug Administration’s Medical Device Safety Action Plan. Released in April, the plan outlines new pre- and post-market authorities, guidance and an expert board under consideration by the agency to improve device security and how device makers disclose and respond to vulnerabilities. “The AHA supports these steps, which would make important improvements to the FDA’s oversight of medical device manufacturers with respect to the security of their products,” the association said. “We urge the FDA to move as quickly as possible to implement them and make public its timeline for the benefit of all stakeholders.” With respect to guidance, AHA said device manufacturers “must be held accountable to proactively minimize risk by building security into products by design, providing security tools to their end-users and updating and patching devices as new intelligence and threats emerge.” The association also recommended including health care providers as a partner on an expert board being contemplated by the agency.

Related News Articles

Insights and Analysis
East Alabama Medical Center in Opelika treated patients in early March for a tornado that claimed 23 lives and underscored the importance of natural disaster…
Headline
The Food and Drug Administration today proposed reclassifying surgical staplers for internal use as moderate-risk rather than low-risk medical devices.
Headline
The AHA and American Association for Physician Leadership today released Leadership Evolve, a collection of digital resources on dyad leadership and workforce…
Insights and Analysis
Learn how an Oregon association collaborated with community stakeholders to produce an evidence-based toolkit to prevent workplace violence.
Headline
Civica Rx, the not-for-profit generic drug company, officially opened its headquarters last week in Lehi, Utah.
Chairperson's File
There is no doubt that enhanced convenience and customer service is where health care is headed.